Curative one-shot systemic virotherapy in murine myeloma

Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management

(2011) S. Vincent Rajkumar   AMERICAN JOURNAL OF HEMATOLOGY

Vesicular stomatitis virus as a treatment for colorectal cancer

(2011) J H Stewart et al.   CANCER GENE THERAPY

Direct Effects of Type I Interferons on Cells of the Immune System

(2011) S. Hervas-Stubbs et al.   CLINICAL CANCER RESEARCH

Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide

(2011) Alan Melcher et al.   MOLECULAR THERAPY

Sodium Iodide Symporter (NIS)-Mediated Radiovirotherapy for Pancreatic Cancer

(2010) Alan R. Penheiter et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Impact of tumor microenvironment on oncolytic viral therapy

(2010) Jeffrey Wojton et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Combining oncolytic virotherapy and tumour vaccination

(2010) Byram W. Bridle et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer

(2010) P Castelo-Branco et al.   GENE THERAPY

The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host

(2010) Z S Guo et al.   GENE THERAPY

Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma

(2009) Kah-Whye Peng et al.   AMERICAN JOURNAL OF HEMATOLOGY

Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-β for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy

(2009) Vassiliki Saloura et al.   HUMAN GENE THERAPY

Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates

(2009) Nathan Jenks et al.   HUMAN GENE THERAPY

Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells

(2009) G. Wollmann et al.   JOURNAL OF VIROLOGY

The molecular characterization and clinical management of multiple myeloma in the post-genome era

(2009) Y Zhou et al.   LEUKEMIA

Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

(2009) Shaji K. Kumar et al.   MAYO CLINIC PROCEEDINGS

Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68

(2009) Y. A. Yu et al.   MOLECULAR CANCER THERAPEUTICS

Oncolytic Vesicular Stomatitis Viruses Are Potent Agents for Intravesical Treatment of High-Risk Bladder Cancer

(2008) B. A. Hadaschik et al.   CANCER RESEARCH

Type I interferon as a stimulus for cross-priming

(2008) A LEBON et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Oncolytic viruses: a novel form of immunotherapy

(2008) Robin J Prestwich et al.   Expert Review of Anticancer Therapy

rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy

(2008) Lan Wu et al.   HUMAN GENE THERAPY

Identification of Interferon-β-Stimulated Genes that Inhibit Angiogenesis In Vitro

(2008) Kevin L. Taylor et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Replication-competent retrovirus vectors for cancer gene therapy

(2007) Chien-Kuo Tai   Frontiers in Bioscience-Landmark